Reyad Dada,Bassim T.  Malas Al-Beirouti,
Scoring System for Patients with Cancer to Weigh Risk/Benefit of Chemotherapy During Outbreak of COVID-19
Journal of Clinical and Medical Case Reports
2020
2733-2268
http://dx.doi.org/10.31487/j.JCMCR.2020.02.07
https://www.sciencerepository.org/scoring-system-for-patients-with-cancer-to-weigh-risk_JCMCR-2020-2-107 
Abstract: Coronavirus disease 2019 (COVID-19) is impacting our daily practice. Hematologist and oncologist around
the globe are concerned and many physicians are hesitating to start/continue antineoplastic treatment in
patients with cancer to protect them from severe complications in case of infection with the new novel
corona virus. Therefore, we feel there is a high demand for scoring system to guide and help physicians
dealing with patients with malignant diseases to take the correct decision. We have designed a scoring
system to evaluate patients with cancer requiring anti-cancer treatment and we have started to implement it
at our hospital. Therefore, we would like to share this scoring system with the community.Keywords: COVID-19, corona virus, cancer treatment